KRAS and neoplasm: Through analysis of available sequences of human tumor samples, generation of transgenic mouse models that express mutant KRAS and EGFR in the lung epithelium, and functional tests of these mutant genes in cultured tumor cells, we conclude that synthetic lethality is responsible for the mutually exclusive nature of activating mutations in these genes.